[1] Moon R C, Thompson H J, Becci P J, et al.N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat [J].Cancer Research, 1979, 39(4):1339-1346.
[2] Hail N, Lotan R.Mitochondrial permeability transition is a central coordination event in N-(4-hydroxyphenyl)retinamide induced Apoptosis [J].Cancer Epidemiology, Biomarkers & Prevention, 2000, 9(12):1293-1301.
[3] Batra S, Reynolds C P, Maurer B J.Fenretinide cytotoxicity for Ewing’s sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators [J].Cancer Research, 2004, 64(15):5415-5424.
[4] Hussein B I, Curley R W, Panigot M J, et al.Chemotherapeutic evaluation of N-(4-hydroxyphenyl)retinamide-O-glucuronide in the rat mammary tumor model [J].Anticancer Research, 1997, 7(5A):3335-3339.
[5] Veronesi U, De Palo G, Marubini E, et al.Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer [J].Journal of the National Cancer Institute, 1999, 91(21):1847-1856.
[6] DiPietrantonio A M, Hsieh T C, Juan G, et al.Fenretinide-induced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation [J].Cancer Research, 2000, 60(16):4331-4335.
[7] Asumendi A, Morales M C, Alvarez A, et al.Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)retinamide-induced apoptosis [J].British Journal of Cancer, 2002, 86(12):1951-1956
[8] Fanjul A N, Delia D, Pierotti M A, et al.4-hydroxyphenyl retinamide is a highly selective activator of retinoid receptors [J].Journal of Biological Chemistry, 1996, 271(37):22441-22446.
[9] Sin H S, Kwon Y J, Han H S, et al.Synthesis and preliminary biological studies of novel retinamide derivatives [J].Bulletin of the Korean Chemical Society, 2002, 23(12):1806-1810.
[10] Um S J, Kwon Y J, Han H S, et al.Synthesis and biological activity of novel retinamide and retinoate derivatives [J].Chemical and Pharmaceutical Bulletin, 2004, 52(5):501-506.
[11] Maryanoff C A.Process for the preparation of N-(4-hydroxyphenyl)-retinamide: US, 5399757[P].1995-03-21.
[12] Oyler A R, Motto M G, Naldi R E, et al.Characterization of autoxidation products of retinoic acid [J].Tetrahedron, 1989, 45(24):679-694.